← Back to Clinical Trials
Recruiting NCT05982262

NCT05982262 Naturopathic-pharmacological Consultation in Hematology

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05982262
Status Recruiting
Phase
Sponsor Bnai Zion Medical Center
Condition Hematologic Diseases
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2023-06-15
Primary Completion 2027-12

Trial Parameters

Condition Hematologic Diseases
Sponsor Bnai Zion Medical Center
Study Type INTERVENTIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-06-15
Completion 2027-12
Interventions
Naturopathic-pharmacological consultation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this cross-sectional study is to learn about the effect of a naturopathic-pharmacologic consultation in patients with hematologic conditions. The main question it aims to answer is whether such consultation can improve the safety of dietary and herbal supplements' use among these patients. Participants will be asked to answer basic questions and fill-out questionnaire before and after meeting the consultation team. Some patients will be prescribed dietary and herbal supplements that may help relief some of the symptoms they describe, in a safe way and without interacting with the drugs they are taking.

Eligibility Criteria

Inclusion Criteria: 1. Followed up for a hematological condition 2. Ability to fill simple questionnaires in Hebrew, Russian or Arabic 3. Indication for consultation: 1. Patient's request to expand knowledge about the use of DHS 2. Patient using DHS 3. Patient's desire to start using DHS 4. Patient that is interested in hearing about the use of DHS for his/her health condition 5. Medical or nursing team's recommendation to take DHS for medical treatment or to improve compliance with conventional treatment. Exclusion Criteria: None

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology